1. Home
  2. LEXX vs BYFC Comparison

LEXX vs BYFC Comparison

Compare LEXX & BYFC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lexaria Bioscience Corp.

LEXX

Lexaria Bioscience Corp.

HOLD

Current Price

$0.57

Market Cap

14.5M

Sector

Health Care

ML Signal

HOLD

Logo Broadway Financial Corporation

BYFC

Broadway Financial Corporation

HOLD

Current Price

$5.96

Market Cap

57.1M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
LEXX
BYFC
Founded
2004
1946
Country
Canada
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Savings Institutions
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
14.5M
57.1M
IPO Year
N/A
1996

Fundamental Metrics

Financial Performance
Metric
LEXX
BYFC
Price
$0.57
$5.96
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$4.00
N/A
AVG Volume (30 Days)
1.4M
6.2K
Earning Date
01-09-2026
01-26-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$705,923.00
$33,412,000.00
Revenue This Year
$13.35
N/A
Revenue Next Year
$78.83
N/A
P/E Ratio
N/A
N/A
Revenue Growth
52.05
N/A
52 Week Low
$0.48
$5.51
52 Week High
$2.43
$9.46

Technical Indicators

Market Signals
Indicator
LEXX
BYFC
Relative Strength Index (RSI) 31.42 47.08
Support Level $0.48 $5.65
Resistance Level $0.70 $6.08
Average True Range (ATR) 0.12 0.28
MACD -0.06 0.01
Stochastic Oscillator 9.27 45.80

Price Performance

Historical Comparison
LEXX
BYFC

About LEXX Lexaria Bioscience Corp.

Lexaria Bioscience Corp is a biotechnology company focused on enhancing the bioavailability of active pharmaceutical ingredients using its patented DehydraTECH drug delivery technology. DehydraTECH improves absorption, effectiveness, and tolerability and can be applied to APIs such as GLP-1 and GIP drugs, vitamins, pain medications, hormones, antivirals, nicotine and cannabinoids across therapeutic areas including diabetes, weight loss, epilepsy, hypertension, and heart disease. It can be used in formats such as tablets, capsules, oral suspensions, foods, beverages, and pouches, and supports pharmaceuticals, nutraceuticals, over-the-counter products, and consumer packaged goods. The Company operates one segment: IP licensing, generating revenue from licensing its DehydraTECH technology.

About BYFC Broadway Financial Corporation

Broadway Financial Corp is active in the financial services domain. It is a savings and loan holding company in the United States. The Bank's business consists of deposits from the general public and using such deposits, together with borrowings and other funds, to make mortgage loans secured by residential properties and commercial real estate. Its deposits consist of passbook savings accounts, checking accounts, and negotiable order of withdrawal accounts, money market accounts and fixed-term certificates of deposit. The revenue is derived from interest income on loans and investments.

Share on Social Networks: